Characteristics of Patients With Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibition in the Pooled Cohort of Patients From the Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and Stand Up To Cancer/Mark Foundation Data Sets, According to TMB Status. This evidence concerns the gene CD274 and cancer.